The importance of total number of sentinel lymph nodes in patients with stage NO cutaneous melanoma

American Journal of Clinical Pathology

Volumn 124, Issue 1, 2005, Pages 77-82

  Stewart, Laura E ^a   Tyler, Douglas S ^a   Vollmer, Robin T ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Melanoma; Metastasis; Probability; Sentinel node; Tumor recurrence

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BAYES THEOREM; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; POISSON DISTRIBUTION; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY;

EID: 21744445071     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/XTR5DA5L3N26JR8J     Document Type: Article

References (44)

1. Balch CM, Soong S-J, Gershenwald JE, et al. Prognostic factor analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer Melanoma Stage System. J Clin Oncol. 2001;19:3622-3634.
2. Balch CM, Buzaid AC, Soong S-J, et al. Final version of the American Joint Committee on Cancer Staging System for cutaneous melanoma. J Clin Oncol. 2001;19:3635-3648.
3. McMasters KM, Reintgen DS, Ross MI, et al. Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement. J Clin Oncol. 2001;19:2851-2855.
4. White DC, Schuler FR, Pruitt SK, et al. Timing of sentinel lymph node mapping after lymphoscintigraphy. Surgery. 1999;126:156-161.
5. Porter GA, Ross MI, Berman RS, et al. How many lymph nodes are enough during sentinel lymphadenectomy for primary melanoma? Surgery. 2000;128:306-311.
6. McMasters KM, Reintgen DS, Ross MI, et al. Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed? Ann Surg Oncol. 2001;8:192-197.
7. Kalady MF, White DC, Fields RC, et al. Validation of delayed sentinel lymph node mapping for melanoma. Cancer J. 2001;7:503-508.
8. Gadd MA, Cosimi AB, Yu J, et al. Outcome of patients with melanoma and histologically negative sentinel lymph nodes. Arch Surg. 1999;134:381-387.
9. Wagner JD, Ranieri J, Evdokimow DZ, et al. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma. Plast Reconstr Surg. 2003;112:486-497.
10. Morton DL, Wen D-R, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392-399.
11. van der Veen H, Hoekstra OS, Paul MA, et al. Gamma probe-guided sentinel node biopsy to select patients with melanoma for lymphadenectomy. Br J Surg. 1994;81:1769-1770.
12. Thompson JF, McCarthy WH, Bosch CMJ, et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res. 1995;5:255-260.
13. Albertini JJ, Cruse W, Rapaport D, et al. Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg. 1996;223:217-224.
14. Pijpers R, Borgstein PJ, Meijer S, et al. Sentinel node biopsy in melanoma patients: dynamic lymphoscintigraphy followed by intraoperative gamma probe and vital dye guidance. World J Surg. 1997;21:788-793.
15. Thompson JF, Niewind P, Uren RF, et al. Single-dose isotope injection for both preoperative lymphoscintigraphy and intraoperative sentinel lymph node identification in melanoma patients. Melanoma Res. 1997;7:500-506.
16. Wells K, Rapaport DP, Cruse CW, et al. Sentinel lymph node biopsy in melanoma of the head and neck. Plast Reconstr Surg. 1997;100:591-594.
17. Bostick PJ, Morton DL, Turner RR, et al. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients. J Clin Oncol. 1999;17:3238-3244.
18. Essner R, Conforti A, Kelley MC, et al. Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma. Ann Surg Oncol. 1999;6:442-449.
19. Gershenwald JE, Thompson W, Mansfield PF, et al. Multiinstitutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol. 1999;17:976-983.
20. Messina JL, Glass LF, Cruse CW, et al. Pathological examination of the sentinel lymph node in malignant melanoma. Am J Surg Pathol. 1999;23:686-690.
21. Morton DL, Thompson JF, Essner R, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Ann Surg. 1999;230:453-465.
22. Wagner JD, Davidson D, Coleman JJ III, et al. Lymph node tumor volumes in patients undergoing sentinel lymph node biopsy for cutaneous melanoma. Ann Surg Oncol. 1999;6:398-404.
23. Blaheta H-J, Ellwanger U, Schittek B, et al. Sentinel node biopsy for melanoma: what is the evidence? J Invest Dermatol. 2000;114:637-642.
24. Casinelli N, Belli F, Santinami M, et al. Sentinel lymph node biopsy in cutaneous melanoma: the WHO melanoma program experience. Ann Surg Oncol. 2000;7:469-474.
25. Cochran AJ. The pathologists role in sentinel lymph node evaluation. Semin Nucl Med. 2000;30:11-17.
26. Jansen L, Nieweg OE, Petersen JL, et al. Reliability of sentinel lymph node biopsy for staging melanoma. Br J Surg. 2000;87:484-489.
27. Wagner JD, Gordon MS, Chuang T-Y, et al. Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma. Cancer. 2000;89:453-462.
28. Clary BM, Brady MS, Lewis JJ, et al. Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with emphasis on recurrence. Ann Surg. 2001;233:250-258.
29. Medino-Franco H, Beenken SW, Heslin MJ, et al. Sentinel node biopsy for cutaneous melanoma in the head and neck. Ann Surg Oncol. 2001;8:716-719.
30. Starz H, Balda B-R, Kramer K-U, et al. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer. 2001;91:2110-2120.
31. Eicher SA, Clayman GL, Myers JN, et al. A prospective study of intraoperative lymphatic mapping for head and neck cutaneous melanoma. Arch Otolaryngol Head Neck Surg. 2002;128:241-246.
32. Hochberg M, Lotem M, Gimon Z, et al. Expression of tyrosinase, MIA and MART-1 in sentinel lymph nodes of patients with malignant melanoma. Br J Dermatol. 2002;146:244-249.
33. Cook MG, Green MA, Anderson B, et al. The development of optimal pathological assessment of sentinel lymph nodes for melanoma. J Pathol. 2003;200:314-319.
34. Estourgie SH, Nieweg OE, Olmos RAV, et al. Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years. Ann Surg Oncol. 2003;10:681-688.
35. Manca G, Facchetti F, Pizzocaro C, et al. Nodal staging in localized melanoma: the experience of the Brescia Melanoma Unit. Br J Plast Surg. 2003;56:534-539.
36. Reeves ME, Delgado R, Busam KJ, et al. Prediction of nonsentinel lymph node status in melanoma. Ann Surg Oncol. 2003;10:27-31.
37. Abrahamsen HN, Hamilton-Dutoit SJ, Larsen J, et al. Sentinel lymph nodes in malignant melanoma: extended histopathologic evaluation improves diagnostic precision. Cancer. 2004;100:1683-1691.
38. Dewilt JHW, Thompson JF, Uren RF, et al. Correlation between preoperative lymphoscintigraphy and metastatic nodal disease sites in 362 patients with cutaneous melanomas of the head and neck. Ann Surg. 2004;239:544-552.
39. Elias N, Tanabe KK, Sober AJ, et al. Is completion lymphadenectomy after a positive sentinel lymph node biopsy for cutaneous melanoma always necessary? Arch Surg. 2004;139:400-405.
40. Tiffet O, Perrot JL, Gentil-Perret A, et al. Sentinel lymph node detection in primary melanoma with preoperative dynamic lymphoscintigraphy and intraoperative γ probe guidance. Br J Surg. 2004;91:886-892.
41. Medalie NS, Ackerman AB. Sentinel lymph node biopsy has no benefit for patients with primary cutaneous melanoma metastatic to a lymph node: an assertion based on comprehensive, critical analysis, part I. Am J Dermatopathol. 2003;25:399-417.
42. Chao C, Wong SL, Ross MI, et al. Patterns of early recurrence after sentinel lymph node biopsy for melanoma. Am J Surg. 2002;184:520-525.
43. Vollmer RT. Analysis of lymph nodal metastasis in malignant melanoma using the Poisson probability paradigm and Bayes rule. Am J Clin Pathol. 2005;123:707-715.
44. Muller MGS, Borgestein PJ, Pijpers R, et al. Reliability of sentinel node procedure in melanoma patients: analysis of failures after long-term follow-up. Ann Surg Oncol. 2000;7:461-468.